- Home
- IFRX vs HFFG Comparison
IFRX vs HFFG Comparison
Compare IFRX & HFFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- HFFG
- Stock Information
- Founded
- IFRX 2007
- HFFG N/A
- Country
- IFRX Germany
- HFFG United States
- Employees
- IFRX N/A
- HFFG N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- HFFG Food Distributors
- Sector
- IFRX Health Care
- HFFG Consumer Discretionary
- Exchange
- IFRX Nasdaq
- HFFG Nasdaq
- Market Cap
- IFRX 143.7M
- HFFG 168.8M
- IPO Year
- IFRX 2017
- HFFG N/A
- Fundamental
- Price
- IFRX $2.47
- HFFG $2.79
- Analyst Decision
- IFRX Strong Buy
- HFFG
- Analyst Count
- IFRX 1
- HFFG 0
- Target Price
- IFRX $8.00
- HFFG N/A
- AVG Volume (30 Days)
- IFRX 174.5K
- HFFG 48.0K
- Earning Date
- IFRX 11-08-2024
- HFFG 03-13-2025
- Dividend Yield
- IFRX N/A
- HFFG N/A
- EPS Growth
- IFRX N/A
- HFFG N/A
- EPS
- IFRX N/A
- HFFG N/A
- Revenue
- IFRX $187,930.00
- HFFG $1,177,258,000.00
- Revenue This Year
- IFRX $392.79
- HFFG $5.18
- Revenue Next Year
- IFRX $156.76
- HFFG $2.73
- P/E Ratio
- IFRX N/A
- HFFG N/A
- Revenue Growth
- IFRX 177.12
- HFFG 1.53
- 52 Week Low
- IFRX $1.17
- HFFG $2.46
- 52 Week High
- IFRX $2.82
- HFFG $5.91
- Technical
- Relative Strength Index (RSI)
- IFRX 53.59
- HFFG 24.89
- Support Level
- IFRX $2.16
- HFFG $2.78
- Resistance Level
- IFRX $2.65
- HFFG $3.09
- Average True Range (ATR)
- IFRX 0.23
- HFFG 0.12
- MACD
- IFRX -0.01
- HFFG -0.03
- Stochastic Oscillator
- IFRX 52.54
- HFFG 1.92
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The Company's business consists of one operating segment; HF Group, which operates solely in the United States. The Company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.